IGFBP3 and melanoma: The serum levels of IGFBP-3 in patients with melanoma are significantly reduced, and a low IGFBP-3 level is associated with metastasis and cancer progression, while IGFBP-3 administration can significantly inhibit the migration and invasion of different melanoma cell lines [34, 35].